Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study.

Moser T, Foettinger F, Hitzl W, Novotna B, Berger T, Bsteh G, Di Pauli F, Hegen H, Kornek B, Langenscheidt D, Sellner J

DOI: 10.1002/acn3.52056
Published: 2024 Jun
Container: Annals of clinical and translational neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/acn3.52056,
  title = {Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study.},
  author = {Moser T and Foettinger F and Hitzl W and Novotna B and Berger T and Bsteh G and Di Pauli F and Hegen H and Kornek B and Langenscheidt D and Sellner J},
  year = {2024},
  journal = {Annals of clinical and translational neurology},
  doi = {10.1002/acn3.52056},
  url = {https://doi.org/10.1002/acn3.52056}
}

RIS

TY  - JOUR
TI  - Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study.
AU  - Moser T
AU  - Foettinger F
AU  - Hitzl W
AU  - Novotna B
AU  - Berger T
AU  - Bsteh G
AU  - Di Pauli F
AU  - Hegen H
AU  - Kornek B
AU  - Langenscheidt D
AU  - Sellner J
PY  - 2024
JO  - Annals of clinical and translational neurology
DO  - 10.1002/acn3.52056
UR  - https://doi.org/10.1002/acn3.52056
ER  -

APA

T, M., F, F., W, H., B, N., T, B., G, B., F, D. P., H, H., B, K., D, L., & J, S. (2024). Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study.. Annals of clinical and translational neurology. https://doi.org/10.1002/acn3.52056

Source records

pubmed · retrieved 2026-09-26T03:42:15.749Z